Princeton Alpha Management’s Novo Nordisk NVO Stock Holding History

Princeton Alpha Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,246	Closed	-$359K	–	819
2016 Q3	$359K	Buy	17,246 +2,096	+14%	+$52K	0.07%	429
2016 Q2	$407K	Buy	+15,150	New	+$415K	0.07%	412
2015 Q1	–	Sell	-17,786	Closed	-$376K	–	827
2014 Q4	$376K	Buy	+17,786	New	+$397K	0.11%	331
2014 Q3	–	Sell	-11,616	Closed	-$268K	–	781
2014 Q2	$268K	Sell	11,616 -18,050	-61%	-$399K	0.06%	479
2014 Q1	$677K	Buy	+29,666	New	+$632K	0.21%	126

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Princeton Alpha Management's NVO Position: Q4 2016 in Review

Princeton Alpha Management sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 17,246 shares — an estimated $359K sold.

Princeton Alpha Management first reported a position in NVO in Q1 2014 and held it in 5 quarters. The position peaked at $677K in Q1 2014. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

Princeton Alpha Management reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
Princeton Alpha Management sold 17,246 Novo Nordisk shares in Q4 2016, an estimated $359K.
Princeton Alpha Management first reported a position in Novo Nordisk in Q1 2014 and held it in 5 quarters.
Princeton Alpha Management's Novo Nordisk position peaked at $677K in Q1 2014.
483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.